Company profile
Flower One Holdings Inc.
OTC: FLOOF · Healthcare · Drug Manufacturers - Specialty & Generic
Canadian filerHQ Vancouver, BCReports USD
#414 of 1,422 Healthcare companies by revenuetop-quartile growth
EA Score
——FH —DQ —GM —SS 32
v0.1 · 5/100 weight · pillars only
↑ 3-yr revenue growth, revenue growth (YoY) · ↓ return on equity, Piotroski F
Methodology →Revenue TTM
$43.0M
Rev growth YoY (TTM)
-20.0%
Net income (FY)
-$24.4M
Employees
38
as of 2026-08-30
Market cap
$4.7k
as of 2026-08-30
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$57.9M$57.9M2021
Net income-$24.4M-$24.4M2021
Operating income-$29.0M-$29.0M2021
Total assets$117.8M$117.8M2021
Liabilities$117.0M$117.0M2021
Equity$856.7k$856.7k2021
Revenue trend
FY2016 – FY2021 · USD
FY16
FY17
FY18
FY19
FY20
FY21
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Flower One Holdings Inc.’s revenue?
Flower One Holdings Inc. booked $57.9M in FY2021 revenue, growing 69% year over year — faster than most Healthcare companies we track, at a -42.2% net margin.
Peers · Healthcare
Fortress Biotech, Inc.62CKestra Medical Technologies, Ltd.——Etao International Co., Ltd.——Champions Oncology, Inc.——CVRx, Inc.50DHLS Therapeutics Inc.64CKey facts
CEOKellen O'Keefe
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersVancouver, BC
ExchangeOTC: FLOOF
Employees38
IPO date2018-10-12
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.